NCT04508244View on ClinicalTrials.gov

Beta Blocker Use In Traumatic Brain Injury Based On The High-Sensitive Troponin T Status

PHASE4UnknownINTERVENTIONAL
Enrollment

771

Participants

Timeline

Start Date

December 29, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
TraumaBrain InjuriesStress ReactionBeta BlockersTroponin
Interventions
DRUG

Placebo

12 ampoules of 1 mg placebo solution (3 ampoules/day for 2 days; 2 ampoules/day for day-3 \& 4 and 1 ampoule/day for day-5 \& 6.

DRUG

Propranolol

12 ampoules of 1 mg placebo solution (3 ampoules/day for 2 days; 2 ampoules/day for day-3 \& 4 and 1 ampoule/day for day-5 \& 6.

Trial Locations (1)

Unknown

RECRUITING

Hamad General Hospital, Doha

Sponsors
All Listed Sponsors
lead

Hamad Medical Corporation

INDUSTRY

NCT04508244 - Beta Blocker Use In Traumatic Brain Injury Based On The High-Sensitive Troponin T Status | Biotech Hunter | Biotech Hunter